Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M van Lint

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Circulation. Genomic and Precision Medicine|December 17, 2024
Recreational and Occupational Physical Activity and Risk of Adverse Events in Truncating <i>MYBPC3</i> Founder Variant CarriersFahima Hassanzada, Mark Jansen, Freyja H M van Lint, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 1, 2024
Long-term reliability of the phospholamban (PLN) p.(Arg14del) risk model in predicting major ventricular arrhythmia: a landmark studyMyrthe Y C van der Heide, Tom E Verstraelen, Freyja H M van Lint, et al.
European Heart Journal|June 11, 2021
Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers-reaching the frontiers of individual risk predictionTom E Verstraelen, Freyja H M van Lint, Laurens P Bosman, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|July 24, 2023
MYH7 p.(Arg1712Gln) is pathogenic founder variant causing hypertrophic cardiomyopathy with overall relatively delayed onsetLuisa Marsili, Freyja H M van Lint, Francesco Russo, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|April 19, 2019
The Netherlands Arrhythmogenic Cardiomyopathy Registry: design and status updateL P Bosman, T E Verstraelen, F H M van Lint, et al.
JACC. Heart Failure|August 9, 2025
Identifying Predictors for Heart Failure Outcomes in Phospholamban p.(Arg14del)-Positive IndividualsMyrthe Y C van der Heide, Tom E Verstraelen, Remco de Brouwer, et al.
European Journal of Heart Failure|April 23, 2025
Age-related penetrance of phospholamban p.Arg14del cardiomyopathyTom E Verstraelen, Freyja H M van Lint, Remco de Brouwer, et al.
Journal of Cardiovascular Translational Research|June 25, 2026
Tracing the pathogenic PLN p.(Arg14del) variant across the globe; more than just a local curiosityEsmée van Drie, Freyja H M van Lint, Rob Zwart, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 26, 2020
An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipidsSacha Ferdinandusse, Kirsty McWalter, Heleen Te Brinke, et al.
Circulation. Genomic and Precision Medicine|December 29, 2022
Variant Location Is a Novel Risk Factor for Individuals With Arrhythmogenic Cardiomyopathy Due to a Desmoplakin (<i>DSP</i>) Truncating VariantEdgar T Hoorntje, Charlotte Burns, Luisa Marsili, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Circulation. Genomic and Precision Medicine|December 17, 2024
Recreational and Occupational Physical Activity and Risk of Adverse Events in Truncating <i>MYBPC3</i> Founder Variant CarriersFahima Hassanzada, Mark Jansen, Freyja H M van Lint, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 1, 2024
Long-term reliability of the phospholamban (PLN) p.(Arg14del) risk model in predicting major ventricular arrhythmia: a landmark studyMyrthe Y C van der Heide, Tom E Verstraelen, Freyja H M van Lint, et al.
European Heart Journal|June 11, 2021
Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers-reaching the frontiers of individual risk predictionTom E Verstraelen, Freyja H M van Lint, Laurens P Bosman, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|July 24, 2023
MYH7 p.(Arg1712Gln) is pathogenic founder variant causing hypertrophic cardiomyopathy with overall relatively delayed onsetLuisa Marsili, Freyja H M van Lint, Francesco Russo, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|April 19, 2019
The Netherlands Arrhythmogenic Cardiomyopathy Registry: design and status updateL P Bosman, T E Verstraelen, F H M van Lint, et al.
JACC. Heart Failure|August 9, 2025
Identifying Predictors for Heart Failure Outcomes in Phospholamban p.(Arg14del)-Positive IndividualsMyrthe Y C van der Heide, Tom E Verstraelen, Remco de Brouwer, et al.
European Journal of Heart Failure|April 23, 2025
Age-related penetrance of phospholamban p.Arg14del cardiomyopathyTom E Verstraelen, Freyja H M van Lint, Remco de Brouwer, et al.
Journal of Cardiovascular Translational Research|June 25, 2026
Tracing the pathogenic PLN p.(Arg14del) variant across the globe; more than just a local curiosityEsmée van Drie, Freyja H M van Lint, Rob Zwart, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 26, 2020
An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipidsSacha Ferdinandusse, Kirsty McWalter, Heleen Te Brinke, et al.
Circulation. Genomic and Precision Medicine|December 29, 2022
Variant Location Is a Novel Risk Factor for Individuals With Arrhythmogenic Cardiomyopathy Due to a Desmoplakin (<i>DSP</i>) Truncating VariantEdgar T Hoorntje, Charlotte Burns, Luisa Marsili, et al.
Pageof 3